1. Mironova M, Gopalakrishna H, Rodriguez Franco G, Holland SM, Koh C, Kleiner DE, Heller T. Granulomatous liver diseases. Hepatol Commun. 2024; 8(4): e0392. doi: 10.1097/
HC9.0000000000000392.
2. Mukhopadhyay S, Farver CF, Vaszar LT, Dempsey OJ, Popper HH, Mani H, et al. Causes of pulmonary granulomas: a retrospective study of 500 cases from seven countries. J Clin Pathol.
2012; 65 (1): 51–57. doi:10.1136/jclinpath-2011-200336.
3. Coash M, Forouhar F, Wu CH, Wu GY. Granulomatous liver diseases: a review. J Formos Med Assoc. 2012;111(1):3-13.
4. Almadi MA, Aljebreen AM, Sanai FM, Marcus V, Almeghaiseeb ES, Ghosh S. New insights into gastrointestinal and hepatic granulomatous disorders. Nat Rev Gastroenterol Hepatol. 2011;8:
455-66.
5. Pereira GH, Yamagutti DC, Mendonça JS. Evaluation of the histopathological hepatic lesions and opportunistic agents in Brazilian HIV patients. Rev Soc Bras Med Trop. 2010; 43:1-3.
6. Sartin JS, Walker RC. Granulomatous hepatitis: A retrospective review of 88 cases at the Mayo Clinic. Mayo Clin Proc. 1991;66: 914-8.
7. Shaikh S, Shaikh RB, Rab SM. Granulomatous hepatitis: Analysis of twenty seven patients. Article. J Coll Phys Surgeons Pak. 1997; 7:235-6.
8. Geramizadeh B, Jahangiri R, Moradi E. Causes of hepatic granuloma: A 12-year single center experience from southern Iran. Arch Iran Med. 2011;14:288–9.
9. Turhan N, Kurt M, Ozderin YO, Kurt OK. Hepatic granulomas: A clinicopathologic analysis of 86 cases. Pathol Res Pract. 2011;207:359-65.
10. Drebber U, Kasper HU, Ratering J, Wedemeyer I, Schirmacher P, Dienes HP, et al. Hepatic granulomas: Histological and molecular pathological approach to differential diagnosis–a study of
442 cases. Liver Int. 2008; 28:828-34
11. Doppalapudi H, Markus JT, Parekh U. Granulomatous Hepatitis. 2022 Oct 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. PMID: 33231985.,
12. Murphy, Kenneth; Paul, Travers; Mark, Walport (2008). Janeway’s immunobiology (7th ed.). New York: Garland Science. p. 372. ISBN 978-0815341239.
13. Lamps LW. Hepatic granulomas, with an emphasis on infectious causes. Adv Anat Pathol. 2008;15:309–18.
14. Kleiner DE. Granulomas in the liver. Semin Diagn Pathol. 2006; 23:161–9.
15. Brunt EM, Kleiner DE, Carpenter DH, Rinella M, Harrison SA, Loomba R, et al. NAFLD: Reporting histologic findings in clinical practice. Hepatology. 2021;73:2028–38.
16. Choi EK, Lamps LW. Granulomas in the liver, with a focus on infectious causes. Surg Pathol Clin. 2018;11:231-50.
17. Rais R, Chatterjee D, McHenry S, Byrnes K. Poorly formed hepatic granulomas: A rare manifestation of acute T cellmediated rejection. Histopathology. 2020;77:847–8.
18. Saw D, Pitman E, Maung M, Savasatit P, Wasserman D, Yeung CK. Granulomatous hepatitis associated with glyburide. Dig Dis Sci. 1996;41(2): 322-5.
19. Yoon JY, Min SY, Park JY, Hong SG, Park SJ, Paik SY, Park YM. A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis. Korean J Hepatol. 2008;14(1): 97-101.
20. Ishak KG, Zimmerman HJ. Drug-induced and toxic granulomatous hepatitis.Baillieres Clin Gastroenterol. 1988;2(2):463-80.
21. James DG, Vella M. Hepatic granulomas. Sarcoidosis. 1986;3(1):30-3.
22. Joshi V, Jain S, Sharma V, Khippal N, Chaturvedi A. Granulomatous Hepatitis with Miliary Mottling: A Rare Cause. J Assoc Physicians India. 2018;66(9):97-8.
23. Saiduo S, Wei W, Jichan J, Xinchun, Hongye, Ning, et al. Clinical manifestation, imaging features and treatment follow-up of 29 cases with hepatic tubercolosis. Mediterr J Hematol Infect Dis.
2022;14:e2022063.
24. Cohen SB, Gern BH, Urdahl KB. The Tuberculous Granuloma and Preexisting Immunity. Annu Rev Immunol. 2022; 40: 589-614. doi: 10.1146/annurev-immunol-093019-125148.
25. Marakalala MJ, Raju RM, Sharma K, Zhang YJ, Eugenin EA, Prideaux B, et al. Inflammatory signaling in human tuberculosis granulomas is spatially organized. Nat Med. 2016;22: 531–8.
26. Yalcin K, Tugba Tuncel E, Ucmak F, Bestas R. Brucellosis as a rare cause of granulomatous hepatitis with hepatic and bone marrow granulomas: A case report. Hepatol Forum. 2021; 2(3):137-
140. doi: 10.14744/hf.2021.2021.0038.
27. Pellegrin M, Delsol G, Auvergnat JC, Familiades J, Faure H, Guiu M, et al. Granulomatous hepatitis in Q fever. Hum Pathol. 1980; 11:51-7.
28. Khonde P, Byrnes K. The Brief Case: Granulomatous hepatitis in an mmunocompromised patient. J Clin Microbiol. 2023;61(9):e0189222. doi: 10.1128/jcm.01892-22.
29. Ávila F, Santos V, Massinha P, Pereira JR, Quintanilha R, Figueiredo A, et al. Hepatic actinomycosis. GE Port J Gastroenterol. 2015;22:19–23.
30. Ha HK, Lee HJ, Kim H, Ro HJ, Park YH, Cha SJ, et al. Abdominal actinomycosis: CT findings in 10 patients. AJR Am J Roentgenol. 1993;161:791–4.
31. Gaspar R, Andrade P, Silva M, Peixoto A, Lopes J, Carneiro F, et al. Hepatic granulomas: A 17-year single tertiary centre experience. Histopathology. 2018;73:240–6.
32. Anderson CS, Nicholls J, Rowland R, LaBrooy JT. Hepatic granulomas: A 15-year experience in the Royal Adelaide Hospital. Med J Aust. 1988;148:71–4.
33. Yamamoto T, Ishii M, Nagura H, Miyazaki Y, Miura M, Igarashi T, et al. Transient hepatic fibrin-ring granulomas in a patient with acute hepatitis A. Liver. 1995;15:276–9.
34. Okuno T, Arai K, Matsumoto M, Shindo M. Epithelioid granulomas in chronic hepatitis C: A transient pathological feature. ArticleJ Gastroenterol Hepatol (Australia). 1995;10:532–7.
35. Da Cunha T, Wu GY. Cytomegalovirus hepatitis in immunocompetent and immunocompromised hosts. J Clin Transl Hepatol. 2021;9:106–15.
36. Nenert M, Mavier P, Dubuc N, Deforges L, Zafrani ES. EpsteinBarr virus infection and hepatic fibrin-ring granulomas. Hum Pathol. 1988;19:608–10.
37. Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol. 2020;73:807–16.
38. Rammaert B, Desjardins A, Lortholary O. New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis. Mycoses. 2012; 55:e74–84.
39. Mukhopadhyay S, Gal AA . Granulomatous lung disease: an approach to the differential diagnosis. Arch Pathol Lab Med. 2010; 134 (5): 669–90. doi:10.5858/134.5.667.
40. Lamps LW, Molina CP, West AB, Haggitt RC, Scott MA. The pathologic spectrum of gastrointestinal and hepatic histoplasmosis. Am J Clin Pathol. 2000;113:64–72.
41. Liu XF, Li Y, Ju S, Zhou YL, Qiang JW. Network analysis and nomogram in the novel classification and prognosis prediction of advanced schistosomiasis japonica. Am J Trop Med
Hyg.2023;108:569–77.
42. Roberts-Thomson IC, Anders RF, Bhathal PS. Granulomatous hepatitis and cholangitis associated with giardiasis. Gastroenterology. 1982;83:480-3.
43. Mañá J, Rubio-Rivas M, Villalba N, Marcoval J, Iriarte A, Molina-Molina M, et al. Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis:
Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain. Medicine (Baltimore). 2017; 96:e7595.
44. Kennedy PTF, Zakaria N, Modawi SB, Papadopoulou AM, Murray-Lyon I, du Bois RM, et al. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol.
2006;18:721–6.
45. Chatzipantelis P, Giatromanolaki A. Early histopathologic changes in primary biliary cholangitis: does ‘minimal change’ primary biliary cholangitis exist? A pathologist’s view. Eur J Gastro-
enterol Hepatol. 2021;33:e7-12.
46. Scheuer PJ. Primary biliary cirrhosis: Diagnosis, pathology and pathogenesis. Postgrad Med J. 1983;59(Suppl 4):106–15.
47. Mendes FD, Levy C, Enders FB, Loftus EV Jr., Angulo P, Lindor KD. Abnormal hepatic biochemistries in patients with inflammatory bowel disease. Am J Gastroenterol. 2007;102:344–50.
48. McCluggage WG, Sloan JM. Hepatic granulomas in Northern Ireland: A thirteen year review. Histopathology. 1994;25: 219-28.
49. Ojha S, Gall T, Sodergren MH, Jiao LR. A case of gossypiboma mimicking intrahepatic cholangiocarcinoma. Ann R Coll Surg Engl. 2014; 96:e14-6.
50. Urban RM, Jacobs JJ, Tomlinson MJ, Gavrilovic J, Black J, Peoc’h M. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement.
J Bone Joint Surg Am. 2000;82:457–76.)
51. Alvarez SZ. Hepatobiliary tuberculosis. J Gastroenterol Hepatol. 1998;13:833–9.
52. Liu GJ, Lu MD, Xie XY, Xu HX, Xu ZF, Zheng YL, et al. Real time contrast-enhanced ultrasound imaging of infected focal liver lesions. J Ultrasound Med. 2008; 27:657–66.
53. Graf C, Arncken J, Lange CM, Willuweit K, Schattenberg JM, Seessle J, et al. Hepatic sarcoidosis: Clinical characteristics and outcome. Jhep Reports. 2021;3:100360.
54. Shah N, Dib EG, Joseph N, Fontana RJ. Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits? Clin Liver Dis (Hoboken). 2024;23(1): e0125. doi: 10.1097/CLD.0000000000000125.
55. Sollors J, Schlevogt B, Schmidt HJ, Woerns MA, Galle PR, Qian Y, et al. Management of hepatic sarcoidosis. J Gastrointestin Liver Dis. 2022;31:323–30